Needham analyst Matt McGinley downgrades Verano Holdings (OTC:VRNOF) from Buy to Hold.
If You Invested $100 In This Stock 20 Years Ago, You Would Have $3,900 Today
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 20 years by 12.59% on an annualized basis producing an average annual return of 20.17%. Currently, Regeneron Pharmaceuticals has a market capitalization of $64.04 billion.
